The pronounced HbA1c-lowering efficacy of GLP-1 agonist analogs in Asian patients has been attributed to several factors, primarily the observation that Asian patients with type 2 diabetes mellitus (T2DM) exhibit lower endogenous GLP-1 levels compared to their non-Asian counterparts [23]
doi: 10.3389/fcell.2025.1619758 Received 28 April 2025 Accepted 13 June 2025 Published 26 June 2025 Volume 13 - 2025 Edited by Marcela Alejandra Michaut, CONICET Dr
Bring recorded home numbers if possible: an unexplained drop in systolic blood pressure greater than 20 mm Hg on standing, persistent systolic readings under 90 mm Hg, or blood glucose consistently under 70 mg/dL are reasonable triggers for medical review
After your first month on semaglutide, you can add the Precision Peptide Genetic Test for just $99 to unlock these personalized dosing recommendations
The SUSTAIN and STEP trial programs for semaglutide, involving thousands of participants followed for up to two years, did not demonstrate an increased overall cancer risk compared to placebo groups
